Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sunitinib in Relapsed/Refractory Germ Cell Cancer
NCT00371553Phase 2Completed
- Sponsor
- BC Cancer
- Start
- Nov 2006
- Primary completion
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sunitinib in Germ cell cancer (GCT), sponsored by BC Cancer. Started Nov 2006; status: completed.
02
Drugs
sunitinib
03
Conditions
Germ cell cancer (GCT)
Beyond the preview
Go deeper on NCT00371553.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00371553.